The Supreme Court on Jan. 16, 2026, agreed to decide a case about how generic companies can communicate to the market about their products, ...

The Supreme Court granted certiorari to review whether a generic drugmaker that fully carves out a patented use from its ...

Delve into the Amarin v. Hikma case in which the U.S. Supreme Court might settle the skinny label question once and for all.

The post The Clear Labels Act Would Change What You Know About Your Prescription Medication appeared first on ProPublica.

The Supreme Court of the US (SCOTUS) has agreed to hear a patent dispute between Amarin and Hikma that could have implications for the legality of 'skinny labels,' which can help generic drugmakers ...

Pushed off by an early March snowstorm, the tussle over whether generics drugmakers should be granted the latitude—or burden, depending on the point of view—to change product labels is being given a ...

Add Yahoo as a preferred source to see more of our stories on Google. Which grocery store brands are people more likely buy and which brand-name products are worth the premium price? Experts explain. ...